Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 25, 2017Clinical Cancer Research

Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

CHCharlotte HurabielleNTNicolas ThonnartCRC. Ram‐Wolff

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hurabielle et al. (2017) studied this question.

synapsesocial.com/papers/6a79bb92756812e395893bb2https://doi.org/10.1158/1078-0432.ccr-16-3185
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases2009 · 703 citations
  2. 2Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 20092012 · 284 citations
  3. 3Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sézary syndrome2009 · 49 citations
  4. 4Significance of circulating T-cell clones in Sezary syndrome2006 · 78 citations